ArticleThe Plant journal : for cell and molecular biology2025
A pectin acetyl-transferase facilitates secondary plasmodesmata formation and RNA silencing movement between plant cells.
Article in The Plant journal : for cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Cell-to-cell connectivity: a future target for crop improvement.Journal of experimental botany · 2026Review
- Three decades of mobile RNA silencing within plants: what have we learnt?Journal of experimental botany · 2026Review
- Plasmodesmata wall biomechanics: challenges and opportunities.Journal of experimental botany · 2026Review
- RNA interference shapes stress responses inFrontiers in plant science · 2025Review
- Mobile RNAs as systemic signaling beyond boundaries for plant stress resistance.Frontiers in plant science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Some silencing small (s)RNAs, comprising micro (mi)RNAs and small-interfering (si)RNAs, move between plant cells to orchestrate gene expression and defense. Besides possible redundancy or embryo lethality, a prevalent challenge in genetic studies of mobile silencing is to discriminate bona fide alterations to sRNA movement from impaired cell-autonomous sRNA activity within silencing-recipient cells. Without such clarifications, cell-to-cell mobility factors are yet to be unequivocally identified. Consequently, known properties of sRNA movement, including contextuality and directionality, remain poorly explained. Circumstantial evidence and synthetic biology pinpoint plasmodesmata (PDs) - the pores traversing plant cell walls (CWs) - as the likely channels involved. Yet, how plants control the number of primary and secondary PDs developing respectively before and after CW formation remains largely unknown. Here, we address these intertwined issues in Arabidopsis using a forward screen for compromised epidermis-to-mesophyll movement of an artificial (a)miRNA. We identify a pectin acetyl-transferase mutation that, we demonstrate, reduces amiRNA physical trafficking but also impedes siRNA, GFP, and viral movement by decreasing the frequency of leaf secondary PDs. sRNA movement at leaf interfaces involving primary PDs remains unaffected, however, as does miRNA and GFP cell-to-cell mobility in roots, hinting at how movement's contextuality and directionality might be achieved. We also show that reducing de-esterified pectin depolymerization decreases leaves' symplasmic connectivity, whereas defective pectin biogenesis increases PD number. Combining genetics with antibody-based pectin probing and atomic force microscopy helps delineate a mechanistically coherent framework whereby pectin esterification and/or abundance impact CW loosening, a process required for CW extension during which secondary PDs form to enable macromolecular trafficking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.